LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-0.29 Cr | ₹8.75 Cr | ₹7.89 Cr | ₹8.47 Cr | ₹2.17 Cr |
What is the latest Cash Flow from Operating Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-0.29 Cr |
| Mar2024 | ₹8.75 Cr |
| Mar2023 | ₹7.89 Cr |
| Mar2022 | ₹8.47 Cr |
| Mar2021 | ₹2.17 Cr |
How is Cash Flow from Operating Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.29 Cr | Negative | |
| Mar2024 | ₹8.75 Cr | 10.79 | |
| Mar2023 | ₹7.89 Cr | -6.78 | |
| Mar2022 | ₹8.47 Cr | 291.09 | |
| Mar2021 | ₹2.17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹120.1 Cr | -6.9% | -5.4% | -42.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -6.9% |
-5.4% |
-42.8% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses